Here are the 424B prospectus supplements from Avita Medical, Inc. (RCEL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow RCEL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RCEL filings page.
AVITA Medical is registering up to 650,000 shares of common stock issuable under a warrant issued to Perceptive Credit Holdings V, LP; 500,000 shares are currently exercisable and an additional 150,000 shares vest only if the Company closes on an Additional Commitment Amount. The Warrant has an exercise price of $3.4019 per share and, if fully cashed-in, could provide the Company with up to approximately $2.2 million of proceeds. The exercise may be paid in cash or by withholding shares (including automatic cashless exercise mechanics), and the exercise window runs to the tenth anniversary of issuance. The registration covers shares issuable upon exercise of the Warrant and notes that the Company will bear registration costs; share issuance could be limited by ASX listing rules but such issuance was approved by stockholders on June 3, 2026.